SEGALA, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 1.795
EU - Europa 856
AS - Asia 174
AF - Africa 24
SA - Sud America 12
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.867
Nazione #
US - Stati Uniti d'America 1.778
IT - Italia 237
SE - Svezia 237
FR - Francia 144
VN - Vietnam 108
PL - Polonia 68
DE - Germania 42
GB - Regno Unito 27
CN - Cina 26
FI - Finlandia 22
CA - Canada 17
IN - India 15
RU - Federazione Russa 15
CZ - Repubblica Ceca 13
UA - Ucraina 12
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 7
BR - Brasile 7
IE - Irlanda 7
NL - Olanda 7
BE - Belgio 6
JP - Giappone 5
AU - Australia 4
CL - Cile 4
DK - Danimarca 4
ID - Indonesia 4
ES - Italia 3
ET - Etiopia 3
LT - Lituania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
HK - Hong Kong 2
TH - Thailandia 2
TR - Turchia 2
ZM - Zambia 2
AL - Albania 1
AT - Austria 1
BJ - Benin 1
BT - Bhutan 1
CM - Camerun 1
DZ - Algeria 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
TZ - Tanzania 1
UG - Uganda 1
ZW - Zimbabwe 1
Totale 2.867
Città #
Santa Cruz 312
Stockholm 234
Fairfield 139
Ashburn 117
Dong Ket 107
Seattle 89
Woodbridge 79
Des Moines 75
Ferrara 69
Warsaw 68
Houston 60
Buffalo 47
Chicago 40
Cambridge 37
Castello Di Fiemme 36
Wilmington 34
Ann Arbor 32
San Diego 28
Paris 24
Santa Maria Di Sala 24
Helsinki 18
Los Angeles 18
New York 18
Las Vegas 15
Dallas 12
Rome 12
Saint Petersburg 10
Boardman 9
Clearwater 9
Provo 9
Henderson 8
Dublin 7
Bengaluru 6
Guangzhou 6
Pune 6
San Jose 6
Scranton 6
Atlanta 5
Auburn 5
Ferrara di Monte Baldo 5
Lake Forest 5
Milan 5
Muizenberg 5
Providence 5
Shanghai 5
Toronto 5
Boulder 4
Brooklyn 4
Grenoble 4
Herndon 4
Miami 4
Reggio Emilia 4
Saskatoon 4
Cedar Knolls 3
Crugers 3
Durban 3
Fleming Island 3
Lombard 3
Lyngby 3
Montreal 3
New Orleans 3
Pavia 3
Recife 3
Reston 3
Riva 3
San Francisco 3
San Mateo 3
Adelaide 2
Bangkok 2
Bologna 2
Bordeaux 2
Bremen 2
Brussels 2
Chandler 2
Chennai 2
Council Bluffs 2
Cypress 2
Denver 2
Dulles 2
Esslingen am Neckar 2
Frankfurt am Main 2
Hamburg 2
Hefei 2
Helsingborg 2
Hong Kong 2
Irpin 2
Jacksonville 2
Lappeenranta 2
Leiden 2
Lincoln 2
Madison 2
Manchester 2
Mountain View 2
Nantes 2
Negrar 2
Omaha 2
Padova 2
Palermo 2
Portland 2
Rochester 2
Totale 2.007
Nome #
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression, file e309ade2-cc68-3969-e053-3a05fe0a2c94 146
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART, file e309ade2-d399-3969-e053-3a05fe0a2c94 101
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART, file e309ade2-c8f7-3969-e053-3a05fe0a2c94 99
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV, file e309ade2-cb76-3969-e053-3a05fe0a2c94 95
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients, file e309ade2-c8f2-3969-e053-3a05fe0a2c94 90
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study, file e309ade2-d3a6-3969-e053-3a05fe0a2c94 85
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014, file e309ade2-d217-3969-e053-3a05fe0a2c94 81
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort, file e309ade2-d360-3969-e053-3a05fe0a2c94 75
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients, file e309ade2-c530-3969-e053-3a05fe0a2c94 74
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort, file e309ade2-d046-3969-e053-3a05fe0a2c94 74
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients, file e309ade2-c109-3969-e053-3a05fe0a2c94 67
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients, file e309ade2-c6af-3969-e053-3a05fe0a2c94 67
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing, file e309ade2-c57b-3969-e053-3a05fe0a2c94 63
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort, file e309ade2-c5f3-3969-e053-3a05fe0a2c94 63
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients, file e309ade2-ca74-3969-e053-3a05fe0a2c94 61
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort, file e309ade2-d39b-3969-e053-3a05fe0a2c94 61
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?, file e309ade2-c600-3969-e053-3a05fe0a2c94 60
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy, file e309ade2-d032-3969-e053-3a05fe0a2c94 60
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study, file e309ade2-d39a-3969-e053-3a05fe0a2c94 60
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study, file e309ade2-d3cb-3969-e053-3a05fe0a2c94 60
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort, file e309ade2-cb06-3969-e053-3a05fe0a2c94 59
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus, file e309ade2-d555-3969-e053-3a05fe0a2c94 59
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy, file e309ade2-c879-3969-e053-3a05fe0a2c94 58
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study, file e309ade2-ca75-3969-e053-3a05fe0a2c94 58
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study, file e309ade2-cb04-3969-e053-3a05fe0a2c94 58
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice, file e309ade2-d556-3969-e053-3a05fe0a2c94 58
A prospective randomized trial on abacavir/ lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study), file e309ade2-cb05-3969-e053-3a05fe0a2c94 57
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?, file e309ade2-cbd4-3969-e053-3a05fe0a2c94 57
Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program, file e309ade2-cd1b-3969-e053-3a05fe0a2c94 56
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort, file e309ade2-d3d4-3969-e053-3a05fe0a2c94 55
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study, file e309ade2-dde7-3969-e053-3a05fe0a2c94 55
Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings, file e309ade4-06ee-3969-e053-3a05fe0a2c94 54
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: A multicentre cohort study Disease epidemiology - Infectious, file e309ade2-c8f4-3969-e053-3a05fe0a2c94 53
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy, file e309ade2-cd76-3969-e053-3a05fe0a2c94 51
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus, file e309ade2-c8f6-3969-e053-3a05fe0a2c94 49
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS, file e309ade0-4933-3969-e053-3a05fe0a2c94 48
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study, file e309ade2-dde1-3969-e053-3a05fe0a2c94 48
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients, file e309ade4-4d45-3969-e053-3a05fe0a2c94 48
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy, file e309ade4-d546-3969-e053-3a05fe0a2c94 42
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort, file e309ade4-6b31-3969-e053-3a05fe0a2c94 41
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison, file e309ade2-cc69-3969-e053-3a05fe0a2c94 36
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort, file c6ffdf39-4b54-4a65-a968-37961066a163 23
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL, file e309ade2-cb0e-3969-e053-3a05fe0a2c94 23
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort, file e309ade4-85e5-3969-e053-3a05fe0a2c94 22
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file e309ade2-dddf-3969-e053-3a05fe0a2c94 20
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV, file e309ade2-dea4-3969-e053-3a05fe0a2c94 18
PITER: An ongoing nationwide study on the real-life impact of direct acting antiviral based treatment for chronic hepatitis C in Italy, file e309ade2-deef-3969-e053-3a05fe0a2c94 18
Optimization of hepatitis C virus screening strategies by birth cohort in Italy, file e309ade4-6c0a-3969-e053-3a05fe0a2c94 17
Incidence and determinants of antiretroviral switching away from TDF-based backbone in the recent years in the Icona Foundation Cohort, file e309ade5-38a6-3969-e053-3a05fe0a2c94 16
null, file e309ade2-c65b-3969-e053-3a05fe0a2c94 15
L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV, file e309ade4-ebaa-3969-e053-3a05fe0a2c94 15
COVID-19 in eastern Emilia: an unusual epidemiology in Northern Italy, file e309ade2-bd27-3969-e053-3a05fe0a2c94 14
Mixed cryoglobulinaemia: An important but frequently unrecognized and underestimated HCV-related condition in the real life practice, file e309ade2-c655-3969-e053-3a05fe0a2c94 14
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort, file e309ade4-9662-3969-e053-3a05fe0a2c94 12
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?, file 73c00d70-a72c-41d2-8988-3535910bf388 10
Optimization of hepatitis C virus screening strategies by birth cohort in Italy, file e309ade4-a68c-3969-e053-3a05fe0a2c94 10
null, file e309ade2-c823-3969-e053-3a05fe0a2c94 8
Multidrug Resistant Bacterial Co-Infections in Critically Ill Patients with COVID-19: A Review after Three Years of Pandemic, file b1308976-d65b-4d41-98b3-7300d9df6e55 6
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome, file e309ade5-16c1-3969-e053-3a05fe0a2c94 6
Identification and molecular characterization of Subramaniula asteroides causing human fungal keratitis: a case report, file 58b6f166-1dd2-46ad-bd56-d27e498dbe17 4
Hepatitis Delta Virus (HDV) infection: frequency and outcome in Persons Living With HIV (PLWH). Data from the ICONA (Italian Cohort of Naïve for Antiretrovirals) cohort, file beb5e75d-fabd-4072-a2fc-c4ceec4f697c 4
Evaluation of HIV Antiretroviral Therapy, Residual Viremia, and Immune Replacement as Possible Factors that Can Affect Systemic Inflammation, file e309ade1-9fc2-3969-e053-3a05fe0a2c94 4
Detection of Parvovirus B19 and Chlamydophila pneumoniae in a Patient with Atypical Sarcoidosis, file e309ade2-a1c1-3969-e053-3a05fe0a2c94 4
Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in Italy, file 08c9d190-e40e-45a4-b66a-926b509035a8 3
Visits to Sexually Transmitted Infection Clinics in Italy from January 2016 to November 2021: A Multicenter, Retrospective Study, file 16d42b2f-86a1-4ad2-9501-685f09e0058d 3
HCV elimination in persons living with HIV (PLWH): the NoCo (No-Coinfection) study of the ICONA network, file c29937a9-cdef-4901-b08b-d29dd5f01fd4 3
Entheseal involvement in asymptomatic human immunodeficiency virus infected patients: preliminary results of a clinical and ultrasonographic study, file e309ade1-e607-3969-e053-3a05fe0a2c94 3
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study, file 7d1c8c25-d49f-41f6-86dd-dfaf7f99f258 2
Expression of toxoplasmic 65 kDa cystic mRNA by RT-PCR in patients with Toxoplasma gondii infection relapses, file e309ade0-2c5a-3969-e053-3a05fe0a2c94 2
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study, file e309ade2-c5ff-3969-e053-3a05fe0a2c94 2
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort *, file e309ade2-c6d3-3969-e053-3a05fe0a2c94 2
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file e309ade2-c6d8-3969-e053-3a05fe0a2c94 2
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison, file e309ade2-cc6a-3969-e053-3a05fe0a2c94 2
Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in Italy, file 1c59a10f-d0e7-41b7-adc5-fdcae4d3097c 1
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort, file 38c5ec04-d04f-4e3b-92d3-4ab6dc1eccdd 1
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study, file 46547b9a-66cb-4f81-ad24-d3570545b889 1
Proportion of PLWH not vaccinated for COVID-19 in Italy and predictors, file ca83d58a-5260-45a8-b5a9-40ddba2fe83c 1
null, file e309ade0-27d2-3969-e053-3a05fe0a2c94 1
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens, file e309ade2-c8ed-3969-e053-3a05fe0a2c94 1
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study, file e309ade2-d3c8-3969-e053-3a05fe0a2c94 1
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort, file e309ade4-93ca-3969-e053-3a05fe0a2c94 1
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients, file e309ade4-e80c-3969-e053-3a05fe0a2c94 1
Totale 2.958
Categoria #
all - tutte 10.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 78
Totale 10.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 1 0 0 0
2020/2021664 0 0 0 39 158 77 40 58 32 74 30 156
2021/2022880 49 27 19 27 65 49 66 65 52 64 297 100
2022/2023935 28 36 256 129 36 75 73 139 62 33 46 22
2023/2024476 30 44 54 20 111 117 21 75 4 0 0 0
Totale 2.958